Found 8 articles for: "dyshidrotic eczema"
May 2021 | Volume 20 | Issue 5 | Original Article | 523 | Copyright © May 2021
Hyperhidrosis (HH) is defined as perspiration beyond the level required to maintain temperature regulation. HH affects nearly 4.8% of the population in the United States. It can have a great impact on...
May 2021 | Volume 20 | Issue 5 | Features | 558 | Copyright © May 2021
October 2019 | Volume 18 | Issue 10 | Features | 1053 | Copyright © October 2019
Dupilumab inhibits the interleukin-4 receptor subunit α and is FDA approved for treatment of moderate-to-severe atopic dermatitis. It is a relatively new drug, and whether it is efficacious for ...
February 2019 | Volume 18 | Issue 2 | Editorials | 211 | Copyright © February 2019
A 44-year-old woman with a history of asthma, hypercholesterolemia, and impaired glucose tolerance presented with severely painful and intensely pruritic plantar dermatitis for more than two years tha...
March 2018 | Volume 17 | Issue 3 | Case Reports | 355 | Copyright © March 2018
March 2018 | Volume 17 | Issue 3 | Original Article | 323 | Copyright © March 2018
IMPORTANCE: Intramuscular (IM) steroids can be used to treat a wide variety of dermatologic diseases. Although seemingly effective and safe, this form of corticosteroid therapy may be underused amongs...
October 2015 | Volume 14 | Issue 10 | Supplement Individual Articles | 42 | Copyright © October 2015
Tinea pedis is a frequently encountered dermatophytosis affecting the superficial skin of the feet, primarily of adults. The prevalence of tinea pedis has increased over the last several decades due t...
Treatment of Mild-to-Moderate Chronic Hand Dermatitis With Clobetasol Propionate 0.05% EF Foam: Results From an Open-Label Study
December 2011 | Volume 10 | Issue 12 | Original Article | 1398 | Copyright © December 2011
Objective: To assess the safety and efficacy of clobetasol propionate 0.05% emulsion formulation (EF) foam in sub...
Media and other results for: "dyshidrotic eczema"
No results found